Repurposing tromethamine as inhaled therapy to treat CF airway disease

Overview of attention for article published in JCI Insight, June 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 11 news outlets
twitter: 4 X users

patent: 5 patents
facebook: 1 Facebook page

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 12 news stories from 11 outlets.

Exemplar Genetics ExeGen® Cystic Fibrosis Research Model Utilized in Development of New Gene Therapy Treatments

Ticker Tech, 13 Sep 2016

SIOUX CENTER, Iowa, Sept. 13, 2016 /PRNewswire/ -- Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE…

Exemplar Genetics ExeGen® Cystic Fibrosis Research Model Utilized in Development of New Gene Therapy Treatments

Ariva, 13 Sep 2016

SIOUX CENTER, Iowa, Sept. 13, 2016 /PRNewswire/ -- Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE…

Exemplar Genetics ExeGen® Cystic Fibrosis Research Model Utilized in Development of New Gene Therapy Treatments

Yahoo! Finance Singapore, 13 Sep 2016

SIOUX CENTER, Iowa, Sept. 13, 2016 /PRNewswire/ -- Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation ( XON …

Exemplar Genetics ExeGen® Cystic Fibrosis Research Model Utilized in Development of New Gene Therapy Treatments

NASDAQ, 13 Sep 2016

SIOUX CENTER, Iowa, Sept. 13, 2016 /PRNewswire/ -- Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE:XON…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 8 additional news stories.